Avid Bioservices (CDMO) Competitor Comparison
We are evaluating the key criteria listed to compare Avid Bioservices (CDMO) against its competitors in the Biotechnology industry.
Market Capitalization
167 / 368Gross Profits
72 / 278Total Revenue
79 / 300EBITDA
33 / 337Free Cashflow
223 / 352Quick Ratio
339 / 357Earnings per Share
225 / 359Dividend yield
0 / 6Total Cash
284 / 358Performance 3 years
191 / 368Performance 5 years
66 / 368Performance 10 years
92 / 368Linearity 3 years
168 / 368Linearity 5 years
145 / 368Linearity 10 years
38 / 368Total Rank
203 / 368Dividend Rank
52 / 368Valuation Rank
187 / 368Piotroski Rank
42 / 368Muliplier Rank
284 / 368Total Revenue - CDMO ranking 79 / 300
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.